Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2014; 20(7): 1833-1838
Published online Feb 21, 2014. doi: 10.3748/wjg.v20.i7.1833
Published online Feb 21, 2014. doi: 10.3748/wjg.v20.i7.1833
Table 1 Clinical characteristics of the PTEN hamartoma tumor syndrome cohort receiving colonoscopy
| n (%) | |
| Patients with colonoscopy | 5 |
| Female sex | 5 (100) |
| Phenotype | |
| Cowden syndrome | 5 (100) |
| BRRS | 0 (0) |
| PTEN mutation | 4 (80) |
| Family history of PHTS | 2 (40) |
| ICC diagnostic criteria[10] | |
| Pathognomonic | |
| Acral keratoses | 1 (20) |
| Papillomatous lesions | 0 (0) |
| Trichilemmomas | 0 (0) |
| Major criteria | |
| Breast cancer | 4 (80) |
| Dysplastic gangliocytoma of the cerebellum | 0 (0) |
| Endometrial cancer | 0 (0) |
| Macrocephaly | 4 (80) |
| Thyroid cancer | 1 (20) |
| Minor criteria | |
| Benign thyroid lesions | 4 (80) |
| Fibroma | 0 (0) |
| Fibrocystic breast disease | 2 (40) |
| Genitourinary tumors | 1 (20) |
| Hamartomatous intestinal polyps | 1 (20) |
| Lipoma | 3 (60) |
| Mental retardation | 0 (0) |
Table 2 Colon findings from the PTEN hamartoma tumor syndrome cohort and systematic review
| Author | OSU cohort | Levi et al[19] | Coriat et al[18] | Stanich et al[16] | Heald et al[14] | Kim et al[17] | Total, all patients | Percentage | Total, + PTEN mutation | Percentage |
| n, with colonoscopy | 5 | 10 | 10 | 10 | 67 | 5 | 107 | 88 | ||
| PTEN mutation | 4 | 10 | NR | 5 | 67 | 2 | 88 | 82% | 88 | 100% |
| Age (yr), mean | 45.8 | 31.7 | 37 | 48 | 36.4 | 34 | 37.4 | 36.9 | ||
| # of colonoscopies, mean | 4.2 | 2.4 | 3.1 | 2 | NR | NR | 2.7 | 2.9 | ||
| Patients with colon polyps | 5 | 8 | 10 | 9 | 62 | 5 | 99 | 92.5% | 81 | 92% |
| > 50 polyps | 1 | NR | 8 | 7 | NR | NR | 16 | 64% | 5 | 55.6% |
| Pancolonic location | 3 | 7 | 7 | 8 | NR | NR | 25 | 71.4% | 14 | 73.7% |
| Left-sided location | 2 | 1 | NR | 1 | NR | NR | 4 | 16% | 3 | 15.8% |
| n, with colonic pathology | 4 | 8 | 10 | 11 | 56 | 5 | 94 | 75 | ||
| Adenocarcinoma | 0 | 1 | 0 | 2 | 9 | 0 | 12 | 12.8% | 12 | 16% |
| Adenoma | 2 | 3 | 10 | 6 | 16 | 1 | 38 | 40.4% | 24 | 32% |
| Ganglioneuroma | 1 | 3 | 5 | 6 | 16 | 0 | 31 | 33% | 23 | 30.7% |
| Hamartoma | 0 | 5 | 6 | 7 | 18 | 0 | 36 | 38.3% | 27 | 36% |
| Hyperplastic | 2 | 8 | 0 | 4 | 27 | 0 | 41 | 43.6% | 39 | 52% |
| Inflammatory | 0 | 0 | 0 | 7 | 11 | 5 | 23 | 24.5% | 18 | 24% |
| Juvenile | 1 | 2 | 0 | 2 | 0 | 0 | 5 | 5.3% | 5 | 6.7% |
| Lymphoid hyperplasia/polyp | 0 | 0 | 0 | 0 | 4 | 1 | 5 | 5.3% | 5 | 6.7% |
| Sessile serrated polyp | 0 | 0 | 0 | 0 | 2 | 0 | 2 | 2.1% | 2 | 2.7% |
| 1 polyp type | 2 | 1 | NR | 2 | 29 | 3 | 37 | 44% | 32 | 42.7% |
| 2 polyp types | 2 | 4 | NR | 2 | 16 | 2 | 26 | 31% | 25 | 33.3% |
| ≥ 3 polyp types | 0 | 3 | NR | 7 | 9 | 0 | 19 | 22.6% | 16 | 21.3% |
-
Citation: Stanich PP, Pilarski R, Rock J, Frankel WL, El-Dika S, Meyer MM. Colonic manifestations of
PTEN hamartoma tumor syndrome: Case series and systematic review. World J Gastroenterol 2014; 20(7): 1833-1838 - URL: https://www.wjgnet.com/1007-9327/full/v20/i7/1833.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i7.1833
